The primary health concern for all individuals living with HIV should be managing their disease, particularly maintaining adherence to their ART treatment. Yet for many, the more immediate demands of their substance use disorder — whether for stimulants and/or opioids — take precedence and can readily become the central focus of their lives. What signals can help a clinician recognize a substance use disorder? How can they differentiate a clinical SUD from intermittent (even though harmful) substance use? What evidence-based treatments should they consider?
Join guest author Dr. Ayesha Appa, a clinician and researcher specializing in HIV/infectious diseases and addiction medicine at the University of California San Francisco, as she shares her knowledge and expertise in the identification and management of substance use disorder in people living with HIV in this issue of eHIV Review.
Describe strategies to improve identification and management of substance use in people living with HIV.
Assistant Professor of Medicine
University of California, San Francisco
Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)
Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)
0.5 hour Physicians
0.5 contact hour Nurses
Launch date: December 10, 2024
Expiration date: December 9, 2026